Teva set to face EU sanction over multiple-sclerosis drug
Teva Pharmaceuticals is set to receive a formal penalty from the European Commission as early as this week, as officials wrap up an investigation into the company's use of intellectual property...To view the full article, register now.
Already a subscriber? Click here to view full article